Dr. Duncan is Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine, and Director of the Immunology of Chronic Lung Disease Program. He attended the University of Washington for both undergraduate studies and medical training.  Addition clinical training in clinical subspecialties occurred at the University of Pittsburgh and Stanford University, and research training in immunology was obtained at Scripps Research Institute. 


Dr. Glenn C. Rowe received his B.S. in Biology from Brandeis University (2001) and his Ph.D. in Molecular, Cellular and Developmental Biology from Yale University (2007) where he studied the transcriptional regulation of factors that control bone and adipose tissue homeostasis. He completed his post-doctoral training at the Beth Israel Deaconess Medical Center, where his work focused on the role of transcriptional coactivators in regulating mitochondrial metabolism.


Suzanne Oparil, MD, FACCSuzanne Oparil, MD, FACC, FAHA, FASH, FAPS is Distinguished Professor of Medicine, Professor of Cell, Developmental and Integrative Biology, Section Chief of Vascular Biology and Hypertension and Director of the Vascular Biology and Hypertension Program of the Division of Cardiovascular Disease in the Department of Medicine at the University of Alabama at Birmingham (UAB). Dr. Oparil graduated with an A.B. degree from Cornell University in 1961, where she was also elected to Phi Beta Kappa, and earned her medical degree from Columbia University College of Physicians and Surgeons (1965) in New York, where she was elected to Alpha Omega Alpha. She received training in internal medicine at Columbia Presbyterian Hospital and then completed her medical residency and cardiology fellowship at Massachusetts General Hospital in Boston.  Dr. Oparil began her career as an Assistant Professor in the Department of Medicine at the University of Chicago in 1971 and received promotion to Associate Professor in 1975.  She joined the UAB faculty as an Associate Professor of Medicine in 1977, was promoted to the rank of Professor in 1981 and subsequently appointed as Director of the UAB Vascular Biology and Hypertension Program, where she has served with extraordinary distinction for over 30 years. Most recently, Dr. Oparil received special recognition for distinguished service to UAB by appointment as Distinguished Professor in the UAB Department of Medicine (2014).


Tiziano Scarabelli, MD, PhD, is an Associate Professor of Medicine in the UAB Division of Cardiovascular Disease. Prior to joining UAB in August 2015, Dr. Scarabelli was an Associate Professor of Medicine at Wayne State University School of Medicine, Detroit, Michigan, and Director of the Center for Heart and Vessel Preclinical Studies, a translational research laboratory based at St. John Hospital and Medical Center, a teaching hospital affiliated with Wayne State University.

Dutton Gareth PhDBiosketch & Research Interests 

Gareth Dutton, PhD, is an Associate Professor of Medicine in the UAB Division of Preventive Medicine. Prior to joining UAB in 2011, Dr. Dutton was an Assistant Professor in the Department of Medical Humanities and Social Sciences at the Florida State University College of Medicine.  Dr. Dutton received his PhD in clinical psychology with an emphasis in behavioral medicine from Louisiana State University.  He completed his pre-doctoral clinical internship at Brown University. Dr. Dutton’s research is focused on the development and evaluation of lifestyle interventions for weight loss and weight loss maintenance. This work includes identification of variables associated with treatment response, including individual factors (e.g., self-efficacy, goal focus, demographic characteristics) and program factors (e.g., size of treatment groups, schedule of treatment contacts, modality of treatment delivery).

Singh Jasvinder MDDr. Singh is a Professor in the Division of Rheumatology and Clinical Immunology. The primary goal of Dr. Singh’s research is to improve the outcomes of patients with arthritis and rheumatic conditions. The objectives of Dr. Singh’s research program are, (1) to advance evidence-based medicine by performing state-of-the-art Cochrane Systematic Reviews, Meta-analyses and Network Meta-analyses as well as the development and dissemination of treatment guidelines that can change the way we provide the best care to patients with rheumatic conditions, and (2) to improve our understanding of what impacts poor patient outcomes, including pain and function in arthritis, and design interventions to improve these outcomes.